"data.ticker"|"data.figi_ticker"|"data.figi"|"data.title"|"data.publication_date"|"data.summary"|"data.url"|"result_count"|"page_size"|"current_page"|"total_pages"|"api_call_credits"
"PFE"|"PFE:US"|"BBG000BR2B91"|"An Irish Town That Manufactures Viagra Boasts of ‘Love Fumes’ in the Air"|"2017-12-08T17:43:09.000+00:00"|"Ringaskiddy residents say they have an extra spring in their step."|"https://finance.yahoo.com/news/irish-town-manufactures-viagra-boasts-174309845.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"A Cancer-Drug Pricing Experiment Just Got More Interesting"|"2017-12-08T17:13:46.000+00:00"|"Pfizer's new PARP-inhibitor trial data suggest more competition and pressure."|"http://finance.yahoo.com/r/c929d796-661c-3c4e-ae20-b0041f381d05/pfizer-talazoparib-data-cancer-drug-price-pressure-risk-rises?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"A Game-Changing Breakthrough Could Be Coming for Hemophilia Patients"|"2017-12-08T13:31:00.000+00:00"|"There&apos;s a new gene therapy in clinical trials that could revolutionize how doctors treat this disease."|"https://finance.yahoo.com/news/game-changing-breakthrough-could-coming-133100101.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer breast cancer drug superior to chemotherapy in Phase III study"|"2017-12-08T13:30:01.000+00:00"|"Patients with advanced breast cancer tied  to an inherited gene mutation who were treated with an  experimental Pfizer Inc drug went about three months  longer before their disease worsened than those who received  chemotherapy in a late stage study, according to data released  on Friday.  The drug, talazoparib, a once daily pill that Pfizer  acquired with its $14 billion purchase of Medivation, belongs to  a class of medicines called PARP inhibitors that may induce  tumor cell death.  Patients in the Phase III study had mutations of the BRCA1/2  genes, the type of mutation that led actress Angelina Jolie to  have preventive breast removal surgery."|"https://finance.yahoo.com/news/pfizer-breast-cancer-drug-superior-133001757.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Talazoparib Significantly Extends Progression-Free Survival in Phase 3 EMBRACA Trial of Patients with Metastatic Breast Cancer"|"2017-12-08T13:30:00.000+00:00"|"Pfizer Inc. today announced that the Phase 3 EMBRACA trial in patients with germline BRCA1/2-positive locally advanced and/or metastatic breast cancer demonstrated superior progression-free survival in patients treated with talazoparib, compared to patients who received physician’s choice standard of care chemotherapy."|"https://finance.yahoo.com/news/talazoparib-significantly-extends-progression-free-133000539.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"How Eli Lilly’s Endocrinology Drugs Are Performing"|"2017-12-08T12:32:58.000+00:00"|"In 3Q17, Eli Lilly’s (LLY) Humalog generated revenues of $696.2 million, ~9% growth on year-over-year (or YoY) basis and 3% growth on a quarter-over-quarter basis."|"http://finance.yahoo.com/r/7781918a-0627-384b-9c0c-364ca50309c6/eli-lillys-endocrinology-drugs-performing?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Republican tax bill makes big winners of Amgen, Gilead and other drugmakers"|"2017-12-08T12:04:00.000+00:00"|"Of all U.S. companies, drugmakers have some of the most cash held outside the country."|"http://finance.yahoo.com/r/0858da82-b044-3dd1-a54d-40e243cf26c6/Story.aspx?guid=097A5FFC-D926-11E7-B6AB-0AA3A34E7FAD&siteid=yhoof2&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer: Talazoparib Extends Progression-Free Survival In Phase 3 Trial"|"2017-12-08T08:43:00.000+00:00"|"Pfizer: Talazoparib Extends Progression-Free Survival In Phase 3 Trial"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EvRZEt2S_-Y/pfizer-talazoparib-extends-progressionfree-survival-in-phase-3-trial-20171208-00340"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Understanding Allergan’s Valuation in December 2017"|"2017-12-07T20:57:52.000+00:00"|"Allergan reported EPS of $4.15 on revenues of $4.03 billion in 3Q17, which was 11.4% higher YoY, compared with its revenues of $3.62 billion in 3Q16."|"http://finance.yahoo.com/r/4ff3300a-0fdd-3512-9a8e-ea27026e8c84/understanding-allergans-valuation-december-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer Reports Updated Data from Phase III Study on Ibrance"|"2017-12-07T20:27:08.000+00:00"|"Pfizer (PFE) releases impressive new data of a post-hoc analysis from a phase III study on the combo therapy of Ibrance and Femara for the first-line treatment of ER+, HER2- metastatic breast cancer."|"https://finance.yahoo.com/news/pfizer-reports-updated-data-phase-202708890.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"[$$] Lighting a Spark for Gene Therapy"|"2017-12-07T18:53:00.000+00:00"|"The promise of gene therapy to cure genetic diseases is underscored by a new article in The New England Journal of Medicine about a treatment for hemophilia B being developed by Spark Therapeutics (ONCE) and Pfizer (PFE).  Spark and Pfizer have highlighted the article, which was based on previously reported data on 10 men who received the treatment and who were followed for about a year.  The gene therapy uses a delivery system of neutered viruses to introduce healthy genes that code for the production of the clotting factor protein into the cells of patients with hemophilia B. A faulty gene caused by an inherited mutation prevents the production of that factor in hemophilia patients."|"http://finance.yahoo.com/r/e720ffc4-b13c-3347-97be-23df6574990d/lighting-a-spark-for-gene-therapy-1512672788?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Levin Capital Strategies, L.p. Buys DowDuPont Inc, Walt Disney Co, Treehouse Foods Inc, Sells ..."|"2017-12-07T17:08:40.000+00:00"|"Levin Capital Strategies L p New Purchases DWDP STX MRK NLSN NYRT TPGE U HUBB MAC TISI JACK Added Positions DIS THS AGN GM CB PF UTX ETN TSN BAC Reduced Positions GE M INTC CVS AXP MS C COT AXL BKU Sold Out DD ZBH"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RC5T3b3om7I/levin-capital-strategies-lp-buys-dowdupont-inc-walt-disney-co-treehouse-foods-inc-sells-cm888413"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"CWABS Asset-Backed Certificates Trust 2007-6 -- Moody's assigns A1 to Pfizer's new sterling notes; stable outlook"|"2017-12-07T16:16:08.000+00:00"|"Rating Action: Moody's assigns A1 to Pfizer's new sterling notes; stable outlook. Global Credit Research- 07 Dec 2017. © 2017 Moody’ s Corporation, Moody’ s Investors Service, Inc., Moody’ s Analytics, ..."|"http://finance.yahoo.com/r/669726ec-2727-3b19-9b0a-71891fa99e1f/viewresearchdoc.aspx?docid=PR_376712&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20171207_PR_376712&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Regulations And Politics Rain On Pharma M&A Parade"|"2017-12-07T14:35:00.000+00:00"|"Deals are getting smaller despite competitive pressures to scale up."|"http://finance.yahoo.com/r/f59e369d-0800-3e18-bd0a-35fbf5cce734/regulations-and-politics-rain-on-pharma-ma-parade?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer Inc. Announces (i) Private Exchange Offer for its 6.500 per cent. Notes due 2038 Open to Certain Investors and Related Tender Offer Open to All Investors and (ii) Tender Offer for its 5.750 per cent. Notes due 2021 and Related Solicitation of Consents"|"2017-12-07T13:00:00.000+00:00"|"Pfizer Inc. today announced that it has commenced a private offer to exchange any and all of its outstanding £1,500,000,000 6.500 per cent."|"https://finance.yahoo.com/news/pfizer-inc-announces-private-exchange-130000418.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"10 Things to Know for Thursday"|"2017-12-07T01:11:31.000+00:00"|"Your daily look at late-breaking news, upcoming events and the stories that will be talked about Thursday:"|"http://finance.yahoo.com/r/5775fb86-c596-36e6-822c-477967242807/10-things-know-thursday-011131287.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Viagra goes generic: Pfizer to launch own little white pill"|"2017-12-06T23:49:32.000+00:00"|"The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence ..."|"https://finance.yahoo.com/news/viagra-goes-generic-pfizer-launch-162306696.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer is releasing its own generic Viagra to stay relevant"|"2017-12-06T23:49:01.000+00:00"|"All good things must come to an end, including the exclusivity of Pfizer’s prized little blue pill. On Dec. 11, some companies that manufacture generic pills will be allowed to start selling their own versions of Pfizer’s Viagra, and the New York-based pharmaceutical company is clinging to its potency pill with all its might. Rather…"|"http://finance.yahoo.com/r/b0756e77-6153-35a6-9e08-2d73150d6df7/pfizer-is-releasing-a-generic-viagra-as-its-patent-expires?utm_source=YPL&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Gene-therapy approach to hemophilia finds success in study, Spark stock surges"|"2017-12-06T22:16:18.000+00:00"|"Spark Therapeutics Inc. stock surged Wednesday afternoon after the company announced positive results from a study of a gene-therapy approach to hemophilia. The drug, developed and tested in a collaboration ..."|"http://finance.yahoo.com/r/578b4056-cec7-3132-ae34-7051165ddcbd/Story.aspx?guid=C755A650-68CA-4027-9BDD-F343662CA363&siteid=yhoof2&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Spark Therapeutics and Pfizer Announce Publication in The New England Journal of Medicine of Interim Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Hemophilia B"|"2017-12-06T22:00:00.000+00:00"|"PHILADELPHIA and NEW YORK, Dec. 06, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, and Pfizer Inc., today announced that ..."|"https://finance.yahoo.com/news/spark-therapeutics-pfizer-announce-publication-220000397.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Viagra goes generic: Pfizer to launch own little white pill"|"2017-12-06T19:49:05.000+00:00"|"The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first generic competition next week."|"https://finance.yahoo.com/video/viagra-goes-generic-pfizer-launch-194905404.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"US Market Indexes Lower on Tuesday"|"2017-12-06T18:07:02.000+00:00"|"U S market indexes were lower on Tuesday The Dow Jones Industrial Average closed at 24 180 64 for a loss of 109 41 points or 0 45 The S amp P 500 Index closed at 2 629 57 for a loss of 9 87 points or 0 37 The Nasdaq Composite closed at 6 762 21 for a loss of 13 15 points or 0 19"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ORU2GpQDaX8/us-market-indexes-lower-on-tuesday-cm887708"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Can Drug/Biotech M&A Rebound Next Year After Bleak 2017?"|"2017-12-06T16:11:10.000+00:00"|"Quite a few pharmaceutical industry mergers may be in the cards in 2018 if the proposed tax reforms are finally approved The U S Senate passed an amended tax reform bill last week thereby successfully passing the second stage The bill will now be presented to a conference committee"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vniq4q2o4ag/can-drugbiotech-ma-rebound-next-year-after-bleak-2017-cm887544"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"See what the IHS Markit Score report has to say about Pfizer Inc."|"2017-12-06T13:00:44.000+00:00"|"Pfizer Inc NYSE:PFE"|"https://finance.yahoo.com/news/see-ihs-markit-score-report-130044597.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer Inc. breached its 50 day moving average in a Bearish Manner : PFE-US : December 6, 2017"|"2017-12-06T12:47:22.000+00:00"|"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Pfizer Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"|"http://finance.yahoo.com/r/996c24e1-6203-3ddb-8639-a324c59b43d3/pfizer-inc-breached-its-50-day-moving-average-in-a-bearish-manner-pfe-us-december-6-2017?yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Updated Data from Phase 3 Trial of IBRANCE® (palbociclib) Plus Letrozole in ER+, HER2- Metastatic Breast Cancer Confirm Improvement in Progression-Free Survival"|"2017-12-06T12:30:00.000+00:00"|"Pfizer Inc. today announced updated progression-free survival results from the Phase 3 PALOMA-2 trial reinforcing the clinical benefit of IBRANCE® combined with letrozole."|"https://finance.yahoo.com/news/updated-data-phase-3-trial-123000210.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Sex, Drugs and That Little Blue Pill"|"2017-12-06T10:00:50.000+00:00"|"The next step on Viagra's journey from medicine to lifestyle: It's going generic."|"http://finance.yahoo.com/r/c9a4457f-b630-3c70-97f4-f3cb3c64749c/viagra-history-from-sex-icon-to-generic-drug?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Frayed Gasket Delaying Astra's ZS-9 Shows Pharma M&A Perils"|"2017-12-06T05:00:00.000+00:00"|"When AstraZeneca Plc paid $2.7 billion for an experimental drugmaker in 2015, it had its sights set on a potential blockbuster medicine. Instead, it got a Texas factory riddled with defects and two scathing ..."|"http://finance.yahoo.com/r/0352f262-0342-39cc-af13-529081213a1e/frayed-gasket-delaying-astra-s-zs-9-shows-perils-of-pharma-m-a?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Levin Capital Strategies, L.p. Buys DowDuPont Inc, Walt Disney Co, Treehouse Foods Inc, Sells ..."|"2017-12-05T20:07:17.000+00:00"|"Levin Capital Strategies L p New Purchases DWDP STX MRK NLSN NYRT TPGE U HUBB MAC TISI JACK Added Positions DIS THS AGN GM CB PF UTX ETN TSN BAC Reduced Positions GE M INTC CVS AXP MS C COT AXL BKU Sold Out DD ZBH"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/puW2rg6vcqQ/levin-capital-strategies-lp-buys-dowdupont-inc-walt-disney-co-treehouse-foods-inc-sells-cm887135"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"ETFs with exposure to Pfizer Inc. : December 5, 2017"|"2017-12-05T18:13:43.000+00:00"|"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pfizer Inc. Here are 5 ETFs with the largest exposure to PFE-US. Comparing the performance and risk of Pfizer Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"|"http://finance.yahoo.com/r/73fa89a1-1045-39cb-8a8c-28c6c49e4cec/etfs-with-exposure-to-pfizer-inc-december-5-2017?yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Biotech Stocks May See a New M&A Wave in 2018"|"2017-12-05T17:15:00.000+00:00"|"Struggling biotech giants could bolster their stocks in 2018 if they acquire smaller drug companies."|"http://finance.yahoo.com/r/8316419d-d165-30ef-a364-2df07c34eef4/biotech-stocks-may-see-new-ma-wave-2018?partner=YahooSA&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Noteworthy ETF Inflows: VYM, JNJ, WFC, PFE"|"2017-12-05T17:12:35.000+00:00"|"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard High Dividend Yield ETF Symbol VYM where we have detected an approximate 102 8 million dollar inflow that s a 0 5 increase week over week"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1bARiUMyvpo/noteworthy-etf-inflows-vym-jnj-wfc-pfe-cm886927"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Have you been 'pwned' in a data breach? Troy Hunt can tell"|"2017-12-05T15:23:19.000+00:00"|"Troy Hunt has collected a trove of 4.8 billion stolen identity records pulled from the darkest corners of the internet — but he isn't a hacker."|"http://finance.yahoo.com/r/02eb128c-724e-34cc-84f0-17b9fb18d659/pwned-data-breach-troy-hunt-152015122.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"5 Top-Ranked Drug Stocks that are Broker Favorites"|"2017-12-05T14:08:24.000+00:00"|"The pharma and biotech sectors have made a nice comeback this year with the NYSE ARCA Pharmaceutical Index gaining 11 7 while the Nasdaq Biotechnology Index is up 17 7 year to date This is in sharp contrast to 2016 which saw pharma and biotech stocks under a lot of pressure with the"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bSerYoi72Mc/5-top-ranked-drug-stocks-that-are-broker-favorites-cm886721"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Bristol-Myers Squibb and Pfizer Alliance Urge People to ‘Tune in to AFib, Take Note of Stroke Risk’"|"2017-12-05T13:00:00.000+00:00"|"The Bristol-Myers Squibb and Pfizer Alliance, the National Stroke Association and iHeartMedia today launched ‘Tune in to AFib, Take Note of Stroke Risk’ to educate the estimated nearly seven million Americans in 2017 living with atrial fibrillation not caused by a heart valve problem about their increased risk of stroke."|"https://finance.yahoo.com/news/bristol-myers-squibb-pfizer-alliance-130000519.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"What Analysts Recommend for Pfizer in November 2017"|"2017-12-05T12:30:02.000+00:00"|"23 analysts were tracking Pfizer in November 2017. One analyst recommended a “strong buy,” while 11 analysts recommended a “buy.”"|"http://finance.yahoo.com/r/cb0f2342-a8fd-3c24-8775-e34c7523dba9/analysts-recommend-pfizer-november-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Regardless of the 'palace intrigue' at the White House, stocks will probably go up: NYSE trader"|"2017-12-04T19:00:00.000+00:00"|"Keith Bliss of Cuttone and Company joins Yahoo Finance's Seana Smith from the floor of the New York Stock Exchange to discuss what's driving the markets this week."|"https://finance.yahoo.com/video/regardless-palace-intrigue-white-house-190048617.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Dow Analyst Moves: PFE"|"2017-12-04T18:16:11.000+00:00"|"The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average Pfizer PFE is the 10 analyst pick Pfizer also comes in above the median of analyst picks among the broader S amp P 500 index components"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kufIqkJWpAw/dow-analyst-moves-pfe-cm886359"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer Wins China & Asia-Pacific Rights to Anti-Fungal Drug"|"2017-12-04T16:13:08.000+00:00"|"Pfizer Inc PFE announced that it has bought exclusive rights to develop and commercialize Swiss company Basilea Pharmaceutica s anti fungal treatment Cresemba isavuconazole in China and other countries in the Asia Pacific region Notably Cresemba is an intravenous IV and oral"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p6X89HpJb8w/pfizer-wins-china-asia-pacific-rights-to-anti-fungal-drug-cm886145"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"3 Stocks That Quadrupled"|"2017-12-04T16:10:46.000+00:00"|"The stock market continues to put on a clinic about how to stomp all over expectations The Dow Jones Industrial Average is up 25 this year and the S amp P 500 is 20 higher but stack them up next to Nektar Therapeutics NASDAQ NKTR Esperion Therapeutics NASDAQ ESPR"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-I0zKSnXwks/3-stocks-that-quadrupled-cm886134"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"A Look at How These Pfizer Drugs Have Performed in 2017"|"2017-12-04T15:30:13.000+00:00"|"In 3Q17, Pfizer’s (PFE) Celebrex generated revenues of $212 million, a ~9% increase on a year-over-year (or YoY) basis and a 19% increase on a quarter-over-quarter basis."|"http://finance.yahoo.com/r/911aeaa1-ee87-348f-9a65-7150a9f29a0d/look-pfizer-drugs-performed-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"3 Reasons Pfizer Should Buy Celgene in 2018"|"2017-12-04T15:10:24.000+00:00"|"You might think it s a crazy idea Maybe it is a crazy idea But sometimes crazy ideas are the ones that wind up being the best So here it is Pfizer NYSE PFE should buy Celgene NASDAQ CELG in 2018 Granted there s a big hurdle with a deal such as this Celgene"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AezTMzNBVzc/3-reasons-pfizer-should-buy-celgene-in-2018-cm886062"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Why the &apos;gay wedding cake&apos; Supreme Court case is really about corporate governance"|"2017-12-04T14:27:19.000+00:00"|"The Supreme Court will hear one of its most politically charged cases on Tuesday, when it takes on the case of a self-described cake artist who refused to make a wedding cake for two men."|"https://finance.yahoo.com/news/gay-wedding-cake-supreme-court-case-really-corporate-governance-142719998.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for December 05, 2017"|"2017-12-04T14:16:50.000+00:00"|"Phibro Animal Health Corporation PAHC will begin trading ex dividend on December 05 2017 A cash dividend payment of 0 1 per share is scheduled to be paid on December 27 2017 Shareholders who purchased PAHC prior to the ex dividend date are eligible for the cash dividend payment"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vpjZIOkzBUM/phibro-animal-health-corporation-pahc-ex-dividend-date-scheduled-for-december-05-2017-cm886032"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer Wins China & Asia-Pacific Rights to Anti-Fungal Drug"|"2017-12-04T14:03:02.000+00:00"|"Pfizer (PFE) inks a deal to buy exclusive rights to develop and commercialize Basilea Pharmaceutica&apos;s anti-fungal treatment, Cresemba, in the Asia-Pacific region and China."|"https://finance.yahoo.com/news/pfizer-wins-china-asia-pacific-140302842.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"3 Reasons Pfizer Should Buy Celgene in 2018"|"2017-12-04T13:32:00.000+00:00"|"A marriage between this big pharma and big biotech could make both companies&apos; shareholders happy."|"https://finance.yahoo.com/news/3-reasons-pfizer-buy-celgene-133200294.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"How Is Pfizer’s Sterile Injection Pharmaceuticals Business Positioned?"|"2017-12-04T12:30:38.000+00:00"|"In 3Q17, Pfizer’s (PFE) Sulperazon reported revenues of $114 million, a ~12% increase on a year-over-year (or YoY) basis and 4% growth on a quarter-over-quarter basis."|"http://finance.yahoo.com/r/8ce3c7b8-d237-3d24-9f77-105480de5186/pfizers-sterile-injection-pharmaceuticals-business-positioned?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Wired News – Pfizer Announced an Agreement to Develop and Commercialize Basilea’s Antifungal CRESEMBA in China and the Asia/ Pacific Region"|"2017-12-04T12:10:00.000+00:00"|"Stock Monitor: Immune Pharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / December 04, 2017 / Active-Investors issued a free report on Pfizer, Inc. (NYSE: PFE ), which is readily accessible upon registration ..."|"https://finance.yahoo.com/news/wired-news-pfizer-announced-agreement-121000444.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"BioNews Capsule: Ready-to-drink Colonoscopy Prep, Viagra Connect, ZYNE's STARS"|"2017-12-04T08:29:00.000+00:00"|"BioNews Capsule: Ready-to-drink Colonoscopy Prep, Viagra Connect, ZYNE's STARS"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gEBnRAeHrpo/bionews-capsule-readytodrink-colonoscopy-prep-viagra-connect-zynes-stars-20171204-00492"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Is a Dividend Cut Coming From GlaxoSmithKline plc?"|"2017-12-02T17:07:28.000+00:00"|"One of the attractions of investing in British drugmaker GlaxoSmithKline plc NYSE GSK is its generous dividend yield which lately has hovered at just a bit less than 6 A yield that s so far out of whack with peers in the industry is an indication that the market is"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nLaDEzuEA6I/is-a-dividend-cut-coming-from-glaxosmithkline-plc-cm885858"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Is a Dividend Cut Coming From GlaxoSmithKline plc?"|"2017-12-02T15:36:00.000+00:00"|"Is the company&apos;s rich yield an opportunity for investors, or a warning of trouble ahead?"|"https://finance.yahoo.com/news/dividend-cut-coming-glaxosmithkline-plc-153600602.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"The 15 All-Time Best-Selling Prescription Drugs"|"2017-12-02T13:11:25.000+00:00"|"Most people may not know it but only a handful out of every thousand drugs that begin development ever make it to the final stages of trials and not all of those are approved Still the low odds of success are worth it to drug companies See what many people may not fully"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nLweZRTu9fw/the-15-all-time-best-selling-prescription-drugs-cm885830"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"3 Drug/Biotech Stocks in Focus on World AIDS Day"|"2017-12-02T01:20:57.000+00:00"|"Every year World Aids Day is celebrated on Dec 1 to raise public awareness about Acquired Immuno Deficiency Syndrome popularly known as AIDS The day is observed to make people aware about proper cure and prevention of the disease In this regard this year the theme for the day this year"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r0u-e5XSxqM/3-drugbiotech-stocks-in-focus-on-world-aids-day-cm885784"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Nestle, Stada prepare rival bids for Germany's Merck consumer health - sources"|"2017-12-01T19:13:44.000+00:00"|"LONDON/FRANKFURT (Reuters) - Swiss food giant Nestle (NESN.S) and the private equity owners of German drug firm Stada (STAGn.DE) are both preparing tentative bids for Merck KgaA's (MRCG.DE) consumer health unit, several sources told Reuters.  Merck's financial adviser JPMorgan has invited bids for the business, which is valued at about 4 billion euros (£3.5 billion), ahead of a Dec. 15 deadline, the sources said.  Nestle is widely seen as a natural buyer for the maker of Seven Seas vitamins and Bion nutritional supplements, after previous talks to set up a consumer joint venture with Merck fell through over the summer."|"https://finance.yahoo.com/news/nestle-stada-prepare-rival-bids-191344461.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Cancer Space Update: Pfizer's Bavencio Fails in Phase III"|"2017-12-01T16:23:56.000+00:00"|"There was no major news in the cancer space this week except the failure of Pfizer Inc s PFE Bavencio in a gastric cancer study In a setback to Eisai Co Ltd ESALY National Institute of Health and Care Excellence NICE did not recommend the approval of its breast cancer drug"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4z7EEcgAdj4/cancer-space-update-pfizers-bavencio-fails-in-phase-iii-cm885408"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"How Pfizer’s Premarin and Other Legacy Established Products Performed"|"2017-12-01T15:31:43.000+00:00"|"In 3Q17, Pfizer's (PFE) Premarin generated revenues of $238 million, a ~2% decline on a YoY basis and a 3% decline on a quarter-over-quarter basis."|"http://finance.yahoo.com/r/dc3ab1ff-5557-3a60-885d-5725a6ddc89f/pfizers-premarin-legacy-established-products-performed?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Glaxo Begins Phase III Study on Injection to Prevent HIV"|"2017-12-01T15:27:06.000+00:00"|"GlaxoSmithKline plc GSK has announced the start of a large late stage African study on an experimental long acting injection for the prevention of HIV ViiV Healthcare an HIV company majorly owned by Glaxo and Pfizer PFE said that the phase III study HPTN 084 will evaluate long"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kbm09DNXfgM/glaxo-begins-phase-iii-study-on-injection-to-prevent-hiv-cm885345"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Gilead & 3 Other Drug Stocks in Focus this World AIDS Day"|"2017-12-01T15:25:51.000+00:00"|"World AIDS Day takes place every year on December 1 with people across the world coming together to fight against HIV to support those living with HIV and to commemorate those who have died from an AIDS related disease Everybody Counts The slogan for this World AIDS Day is"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zoPjJ6vctMg/gilead-3-other-drug-stocks-in-focus-this-world-aids-day-cm885325"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Better Buy: Pfizer Inc. vs. Johnson & Johnson"|"2017-12-01T15:22:39.000+00:00"|"With only one month remaining in 2017 it s pretty clear which big pharma stock has been the better pick this year between Pfizer NYSE PFE and Johnson amp Johnson NYSE JNJ J amp J s share price is up more than 20 while Pfizer stock is only up a little over half as"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5iZpHTae0KI/better-buy-pfizer-inc-vs-johnson-johnson-cm885313"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Cancer Space Update: Pfizer&apos;s Bavencio Fails in Phase III"|"2017-12-01T14:33:02.000+00:00"|"The only major development in the cancer space this week was the failure of Pfizer&apos;s (PFE) Bavencio in a phase III gastric cancer study."|"https://finance.yahoo.com/news/cancer-space-pfizer-apos-bavencio-143302662.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"How Is Pfizer’s Immunology and Inflammation Portfolio Positioned Now?"|"2017-12-01T14:01:37.000+00:00"|"In 3Q17, Pfizer's (PFE) Xeljanz generated revenues of $348 million, a ~48% increase on a year-over-year (or YoY) basis and 4% growth on a quarter-over-quarter basis."|"http://finance.yahoo.com/r/ebc4b358-c1be-38c5-adf7-7b637019d163/pfizers-immunology-inflammation-portfolio-positioned-now?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Understanding Eli Lilly’s Valuation This November"|"2017-12-01T14:01:20.000+00:00"|"In 3Q17, Eli Lilly surpassed the analysts’ estimates for EPS (earnings per share) and revenues, reporting EPS of $1.05 on revenues of ~$5.7 billion."|"http://finance.yahoo.com/r/b6702a76-f5d5-3b41-b50f-5ac55960093b/understanding-eli-lillys-valuation-november?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Better Buy: Pfizer Inc. vs. Johnson & Johnson"|"2017-12-01T13:42:00.000+00:00"|"One of these pharma giants clearly wins in two out of three key criteria for investors."|"https://finance.yahoo.com/news/better-buy-pfizer-inc-vs-134200149.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pharma Stock Roundup: Pfizer/Merck KGaA Drug Fails in Study, Teva CEO Announces Changes"|"2017-12-01T13:23:27.000+00:00"|"While reports about tech giant Amazon meeting generic drugmakers made the rounds companies like Pfizer PFE and Teva Pharmaceutical Industries Ltd s TEVA were in the news with the former reporting late stage data and the latter announcing leadership and organizational changes Recap of"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Uwxy8IhcQNw/pharma-stock-roundup-pfizermerck-kgaa-drug-fails-in-study-teva-ceo-announces-changes-cm885246"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"See what the IHS Markit Score report has to say about Pfizer Inc."|"2017-12-01T13:00:28.000+00:00"|"Pfizer Inc NYSE:PFE"|"https://finance.yahoo.com/news/see-ihs-markit-score-report-130028609.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"How Pfizer’s Established Products Have Performed"|"2017-12-01T12:31:31.000+00:00"|"In 3Q17, Pfizer’s (PFE) Lipitor reported revenues of $491 million, a ~16% increase on a year-over-year (or YoY) basis and ~10% growth on a quarter-over-quarter basis."|"http://finance.yahoo.com/r/ec863c24-e52f-3232-bb23-4dbd3549e516/pfizers-established-products-performed?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pharma Stock Roundup: Pfizer/Merck KGaA Drug Fails in Study, Teva CEO Announces Changes"|"2017-12-01T11:00:11.000+00:00"|"Key highlights this week include changes announced by Teva&apos;s CEO and Pfizer (PFE)/Merck KGaA&apos;s data presentation. Reports about Amazon&apos;s plans to enter the drug market also made headlines."|"https://finance.yahoo.com/news/pharma-stock-roundup-pfizer-merck-110011876.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer Enters into Agreement to Develop and Commercialize CRESEMBA® (isavuconazole) in China and Asia Pacific Region"|"2017-12-01T06:22:00.000+00:00"|"Pfizer Inc. and Basilea Pharmaceutica Ltd. , an international biopharmaceutical company specializing in the research and development of anti-infective and oncological medicines, today announced they have entered into an agreement whereby Pfizer will be granted the exclusive development and commercialization rights in China and several countries in the Asia Pacific region to CRESEMBA ."|"https://finance.yahoo.com/news/pfizer-enters-agreement-develop-commercialize-062200755.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Basilea Pharma Extends License Agreement For Cresemba To China, Asia Pacific"|"2017-12-01T01:39:00.000+00:00"|"Basilea Pharma Extends License Agreement For Cresemba To China, Asia Pacific"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bf4uM0v_wYE/basilea-pharma-extends-license-agreement-for-cresemba-to-china-asia-pacific-20171201-00046"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Why Pfizer And Four More GARP Stocks Look Good"|"2017-11-30T22:49:01.000+00:00"|"A no man’s land can be a dangerous spot. But in the case of GARP stocks, it may be a good place"|"https://finance.yahoo.com/news/why-pfizer-four-more-garp-224901564.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"After Hours Most Active for Nov 30, 2017 :  WFT, F, AUY, ACWI, NAVI, NUAN, MSFT, NUE, V, FWONK, MU, PFE"|"2017-11-30T21:59:43.000+00:00"|"The NASDAQ 100 After Hours Indicator is down 7 8 to 6 357 76 The total After hours volume is currently 53 539 119 shares traded The following are the most active stocks for the after hours session Weatherford International plc WFT is unchanged at 3 30 with 7 596"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UOcD_AR8TzI/after-hours-most-active-for-nov-30-2017-wft-f-auy-acwi-navi-nuan-msft-nue-v-fwonk-mu-pfe-cm885102"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Glaxo Stock Down So Far This Year: Is a Reversal in Store?"|"2017-11-30T16:28:11.000+00:00"|"GlaxoSmithKline plc s GSK shares have declined 7 9 this year so far underperforming the 16 2 increase witnessed by the industry The British pharma and consumer giant s stock was on a rising trajectory till the announcement of third quarter results on Oct 25 On the call"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4ofmI1BZVOo/glaxo-stock-down-so-far-this-year-is-a-reversal-in-store-cm884700"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"How Has Pfizer’s Internal Medicine Portfolio Performed in 2017?"|"2017-11-30T15:31:42.000+00:00"|"In 3Q17, Pfizer’s (PFE) Lyrica reported revenues of $1.3 billion, which is ~4% growth on a year-over-year (or YoY) basis and 2% growth on a quarter-over-quarter basis."|"http://finance.yahoo.com/r/6eb39938-784b-3dd3-8e27-b44e18389873/pfizers-internal-medicine-portfolio-performed-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Glaxo Stock Down So Far This Year: Is a Reversal in Store?"|"2017-11-30T14:19:02.000+00:00"|"Glaxo&apos;s shares have declined 7.9% this year so far."|"https://finance.yahoo.com/news/glaxo-stock-down-far-reversal-141902195.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"An Update on Pfizer’s Xalkori and Inlyta"|"2017-11-30T14:01:55.000+00:00"|"In 3Q17, Pfizer’s (PFE) Xalkori reported revenues of $146 million, which is ~4% growth on a year-over-year (or YoY) basis and 6% growth on a quarter-over-quarter basis."|"http://finance.yahoo.com/r/f5f43e82-3f44-3313-924c-346201c89b51/update-pfizers-xalkori-inlyta?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Bank of America Acts on Bristol-Myers Squibb and Pfizer"|"2017-11-30T13:19:13.000+00:00"|"Bank of America Merrill Lynch took action on Bristol Myers Squibb Company BMY and on Pfizer Inc PFE Bank of America Merrill Lynch took action on Bristol Myers Squibb Company BMY and on Pfizer Inc PFE Bank of America Merrill Lynch has restored its rating of neutral on"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L-99jiIkbbQ/bank-of-america-acts-on-bristol-myers-squibb-and-pfizer-cm884508"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"See what the IHS Markit Score report has to say about Pfizer Inc."|"2017-11-30T13:00:31.000+00:00"|"Pfizer Inc NYSE:PFE"|"https://finance.yahoo.com/news/see-ihs-markit-score-report-130031811.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"How Have Pfizer’s Ibrance and Sutent Performed in 2017?"|"2017-11-30T12:33:54.000+00:00"|"In 3Q17, Pfizer’s (PFE) Ibrance generated revenues of $878 million, a ~60% increase on year-over-year (or YoY) basis and ~3% growth on a quarter-over-quarter basis."|"http://finance.yahoo.com/r/093f8213-524b-32cb-973d-710c16a6ac7f/pfizers-ibrance-sutent-performed-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Better Buy: GlaxoSmithKline plc vs. Pfizer"|"2017-11-30T12:21:46.000+00:00"|"Big drug companies can add an element of stability to investor portfolios People get sick and need treatment whether the economy is booming or tanking And big pharma tends to pay hefty dividends a valuable source of steady income in an era of low returns on fixed income"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6OyF_3kUkRI/better-buy-glaxosmithkline-plc-vs-pfizer-cm884485"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Better Buy: GlaxoSmithKline plc vs. Pfizer"|"2017-11-30T11:02:00.000+00:00"|"Want dependable and rising dividends with potential for long-term capital growth? One of these companies stands out."|"https://finance.yahoo.com/news/better-buy-glaxosmithkline-plc-vs-110200557.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"APNewsBreak: Doctor: Lack of drugs led to new execution plan"|"2017-11-29T23:53:59.000+00:00"|"LAS VEGAS (AP) — A scarcity of lethal injection drugs nationwide drove plans to use a never-before-tried three-drug combination for Nevada's first execution in more than 11 years, the state's former top doctor told The Associated Press."|"http://finance.yahoo.com/r/bbe554d0-9d40-39d7-b363-8685b7d50586/apnewsbreak-doctor-says-drug-scarcity-drove-execution-plan-195221601.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"APNewsBreak: Doctor: Lack of drugs led to new execution plan"|"2017-11-29T23:53:58.000+00:00"|"A scarcity of lethal injection drugs nationwide drove plans to use a never-before-tried three-drug combination for Nevada's first execution in more than 11 years, the state's former top doctor told The ..."|"https://finance.yahoo.com/news/apnewsbreak-doctor-says-drug-scarcity-drove-execution-plan-195221601.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"GOP Corporate Tax Cuts Take Friendly Fire From Corker, Rubio"|"2017-11-29T19:19:51.000+00:00"|"The GOP fiscal hawks who want to pull the trigger on tax hikes if rosy growth projections don t pan out have the 20 corporate tax rate in their sites So do the Senate Republican family first duo of Sens Marco Rubio and Mike Lee who want to limit the corporate rate cut to 22 to pay"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-O2ruZ9CQWc/gop-corporate-tax-cuts-take-friendly-fire-from-corker-rubio-cm883477"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"GOP Corporate Tax Cuts Take Friendly Fire From Corker, Rubio"|"2017-11-29T19:10:46.000+00:00"|"New proposals from Senate holdouts have raised the risk that the benefits of the GOP&apos;s corporate tax bill will be watered down."|"http://finance.yahoo.com/r/261a5685-6180-3bd6-b30d-fcc811dff9af/apple-alphabet-may-be-big-winners-as-gop-tax-bill-nears-a-vote?src=A00220&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"U.S. says patient charity helped drugmakers, revokes approval"|"2017-11-29T19:10:44.000+00:00"|"One of the largest U.S. patient  assistance charities may close after the federal government  revoked its authorization, citing findings that the group,  mainly funded by pharmaceutical companies, enabled drugmakers to  influence prescriptions.  The Department of Health and Human Services' Office of  Inspector General notified Caring Voice Coalition in a letter on  Tuesday that it would rescind the charity's 2006 authorization  after finding that it may have given drugmakers more ability to  raise prices while insulating patients from the immediate  effects of increases, leaving federal health care programs like  Medicare to bear the cost."|"https://finance.yahoo.com/news/u-says-patient-charity-helped-191044223.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer/Merck KGaA's Bavencio Fails in Gastric Cancer Study"|"2017-11-29T18:23:57.000+00:00"|"Pfizer Inc PFE and its Germany based partner Merck KGaA MKGAF announced that a phase III study evaluating their key pipeline candidate avelumab for the treatment of gastric cancer in the third line setting failed to meet the primary endpoint The JAVELIN Gastric 300 trial study"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZbXPykEZX90/pfizermerck-kgaas-bavencio-fails-in-gastric-cancer-study-cm884167"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Bank of America Acts on Bristol-Myers Squibb and Pfizer"|"2017-11-29T16:37:32.000+00:00"|"The US firm restored its rating on Bristol-Myers Squibb to neutral and returned to a buy rating on Pfizer"|"https://finance.yahoo.com/news/bank-america-acts-bristol-myers-163732487.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer/Merck KGaA&apos;s Bavencio Fails in Gastric Cancer Study"|"2017-11-29T16:11:04.000+00:00"|"Pfizer & Merck KGaA&apos;s (MKGAF) Bavencio/avelumab fails in a phase III study evaluating it for the treatment of gastric cancer in the third-line setting."|"https://finance.yahoo.com/news/pfizer-merck-kgaa-apos-bavencio-161104647.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"How Are Pfizer’s Vaccines and Biosimilars Positioned after 3Q17?"|"2017-11-29T15:34:38.000+00:00"|"In 3Q17, Pfizer’s vaccines business generated revenues of $1.6 billion, which reflected ~1% growth on a year-over-year (or YoY) basis."|"http://finance.yahoo.com/r/811b9eab-caee-33e0-82cb-17cd816994f3/pfizers-vaccines-biosimilars-positioned-3q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"3 Top Big Pharma Stocks to Buy Now"|"2017-11-29T15:22:53.000+00:00"|"Big pharma stocks have been longtime favorites among investors for several reasons The fact that they re big means that that they generate huge cash flow which typically translates to attractive dividends And big pharma companies operate in a growing industry with demand"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pDTh7vktzLY/3-top-big-pharma-stocks-to-buy-now-cm883906"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Health Care Sector Update for 11/29/2017: JNJ, PFE, ABT, MRK, AMGN, KOOL, CAPR, RXII"|"2017-11-29T14:39:24.000+00:00"|"Top Health Care Stocks Top Health Care Stocks JNJ 0 1 JNJ 0 1 PFE 0 1 PFE 0 1 ABT 0 3 ABT 0 3 MRK 0 2 MRK 0 2 AMGN 0 1 AMGN 0 1 Health care shares were mostly higher in pre market trading Wednesday Health care shares were mostly higher inpre market trading"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/miYGHWIGAQM/health-care-sector-update-for-11292017-jnj-pfe-abt-mrk-amgn-kool-capr-rxii-cm883895"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Perrigo Company (PRGO) Ex-Dividend Date Scheduled for November 30, 2017"|"2017-11-29T14:26:08.000+00:00"|"Perrigo Company PRGO will begin trading ex dividend on November 30 2017 A cash dividend payment of 0 16 per share is scheduled to be paid on December 19 2017 Shareholders who purchased PRGO prior to the ex dividend date are eligible for the cash dividend payment This marks the"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4KNvxn69dWk/perrigo-company-prgo-ex-dividend-date-scheduled-for-november-30-2017-cm883804"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"How Is Pfizer’s Xtandi Positioned after 3Q17?"|"2017-11-29T14:04:27.000+00:00"|"In 3Q17, Pfizer (PFE) generated revenues of $150 million from sales of Xtandi."|"http://finance.yahoo.com/r/b30cafc7-30d8-3233-8844-3d5c47b7fe53/pfizers-xtandi-positioned-3q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"3 Top Big Pharma Stocks to Buy Now"|"2017-11-29T13:42:00.000+00:00"|"These big pharma stocks should be big winners for investors over the long run."|"https://finance.yahoo.com/news/3-top-big-pharma-stocks-134200775.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Could Lorlatinib Be a Long-Term Growth Driver for Pfizer?"|"2017-11-29T12:35:02.000+00:00"|"Lorlatinib is Pfizer’s (PFE) investigational next-generation ALK/ROS-1 tyrosine kinase inhibitor in clinical trials to evaluate its safety and efficacy in the treatment of ALK-positive metastatic non-small ..."|"http://finance.yahoo.com/r/c3baa9e3-1180-3bdb-b154-9bbc928dcfbb/lorlatinib-long-term-growth-driver-pfizer?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Biotech Stocks Facing FDA Decision In December"|"2017-11-29T07:09:00.000+00:00"|"Biotech Stocks Facing FDA Decision In December"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OCtKog-Lxnc/biotech-stocks-facing-fda-decision-in-december-20171129-00306"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"EARS Pinched By HEALOS Data, EGLT Does It Again, JAVELIN Gastric 300 Misses Mark"|"2017-11-29T02:05:00.000+00:00"|"EARS Pinched By HEALOS Data, EGLT Does It Again, JAVELIN Gastric 300 Misses Mark"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ff0jYh7v44Y/ears-pinched-by-healos-data-eglt-does-it-again-javelin-gastric-300-misses-mark-20171129-00057"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Glaxo, Pfizer's ViiV Healthcare Begins HIV Drug Combo Study"|"2017-11-29T00:21:12.000+00:00"|"GlaxoSmithKline GSK along with partner Pfizer Inc PFE announced that its HIV focused company ViiV Healthcare has initiated a phase III program to evaluate combination of long acting injectable cabotegravir and Johnson amp Johnson s JNJ rilpivirine for treating adults with"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BSHAIfnwwMQ/glaxo-pfizers-viiv-healthcare-begins-hiv-drug-combo-study-cm883639"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"How Did Pfizer Perform in 3Q17?"|"2017-11-28T22:11:04.000+00:00"|"In 3Q17, Pfizer (PFE) generated revenues of $13.2 billion, an increase of ~1% on a year-over-year (or YoY) basis and a 1% increase on a quarter-over-quarter basis."|"http://finance.yahoo.com/r/04cf980c-c3ee-3694-8b5c-541a913d6b3a/how-did-pfizer-perform-in-3q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Glaxo, Pfizer&apos;s ViiV Healthcare Begins HIV Drug Combo Study"|"2017-11-28T21:53:09.000+00:00"|"Glaxo (GSK) and partner Pfizer&apos;s ViiV Healthcare commences a phase III study on combo regimen of cabotegravir and rilpivirine for treatment of adults with virally suppressed HIV-1 infection."|"https://finance.yahoo.com/news/glaxo-pfizer-apos-viiv-healthcare-215309143.html?.tsrc=rss"|4893|100|1|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"3 Dividend Stocks That Cut Bigger Checks Than Chevron"|"2017-11-28T21:11:14.000+00:00"|"Chevron Corporation should be at the top of any dividend investor s short list right now considering that it pays its investors an enviable 3 7 yield But as good as that is the oil and gas company isn t the only stock that s pushing the boundaries of dividend"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/29E5RYoQHqI/3-dividend-stocks-that-cut-bigger-checks-than-chevron-cm883490"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"How Large Is Pfizer's Biosimilar Opportunity?"|"2017-11-28T20:00:00.000+00:00"|"Roche recently sued Pfizer , stating that the latter’s biosimilar for Herceptin amounts to patent infringement. Roche has nearly $2.5 billion in sales at stake. We believe that these lawsuits are going to be increasingly common as Roche and other companies fiercely defend their biologic sales"|"http://finance.yahoo.com/r/7a8fac8d-68aa-3242-9310-b4886c94f875/how-large-is-pfizers-biosimilar-opportunity?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Health Care Sector Update for 11/28/2017: COOL,PZRX,PETX, MDT,GILD,PFE"|"2017-11-28T18:08:53.000+00:00"|"Top Health Care StocksTop Health Care Stocks JNJ 1 42 JNJ 1 42 PFE 0 70 PFE 0 70 ABT 0 26 ABT 0 26 MRK 0 69 MRK 0 69 AMGN 0 16 AMGN 0 16 Health care stocks were gaining with the NYSE Health Care Index rising almost 0 5 while shares of health care companies in the S amp P 500"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sgRIFZHK5ns/health-care-sector-update-for-11282017-coolpzrxpetx-mdtgildpfe-cm883392"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Brace for More Cancer-Drug Trial Failures"|"2017-11-28T16:47:23.000+00:00"|"Immuno-oncology drugmakers are taking bigger risks for a competitive edge."|"http://finance.yahoo.com/r/adf9c351-800c-36ab-899d-81a650d9a9ae/brace-for-more-cancer-drug-trial-failures?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"2 Large-Cap Drug Stocks Missing Out on Industry Rally in '17"|"2017-11-28T16:10:42.000+00:00"|"After the drug pricing issue crippled its performance last year the drug biotech industry except for a small correction recently has witnessed a turnaround this year Stocks with large market cap have done particularly well After declining 5 2 last year the Large Cap Pharma industry"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vZLVoBBM26Y/2-large-cap-drug-stocks-missing-out-on-industry-rally-in-17-cm883161"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"UK gives Pfizer world's first over-the-counter Viagra approval"|"2017-11-28T16:04:22.000+00:00"|"Pfizer's (PFE.N) big-selling erectile dysfunction drug Viagra has been given a green light for sale without a prescription in Britain, the first country to grant it over-the-counter status.  Viagra has been one of the pharmaceutical industry's most successful prescription products since its launch in 1998, following a serendipitous discovery of its effects by researchers who had been studying it as a heart medicine.  It achieved peak worldwide sales of more than $2 billion in 2012 but sales have since declined as patents have expired, prompting Pfizer to explore extending its brand value as a non-prescription drug."|"https://finance.yahoo.com/news/uk-gives-pfizer-worlds-first-152143026.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial"|"2017-11-28T15:30:32.000+00:00"|"Germany's Merck KGaA  has suffered a setback in the development of key cancer  immunotherapy Bavencio, it having failed in a trial to prolong  lives in gastric cancer patients when compared with standard  chemotherapy.  Bavencio, or avelumab, which Merck is jointly developing  with Pfizer, did not meet the primary goal of prolonging  overall survival in patients whose cancer had returned or spread  despite two prior treatment rounds, the two companies said in a  statement on Tuesday."|"https://finance.yahoo.com/news/merck-kgaa-pfizers-immunotherapy-fails-143702065.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Health Care Sector Update for 11/28/2017: JNJ, PFE, ABT, MRK, AMGN, EARS, EGLT, AZN"|"2017-11-28T14:27:03.000+00:00"|"Top Health Care Stocks Top Health Care Stocks JNJ 0 3 JNJ 0 3 PFE 0 5 PFE 0 5 ABT flatABT flat MRK flatMRK flat AMGN flatAMGN flat Health care shares were mostly inactive in pre market trading Tuesday Health care shares were mostly inactive inpre market trading Tuesday"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/POIr8FwGX2w/health-care-sector-update-for-11282017-jnj-pfe-abt-mrk-amgn-ears-eglt-azn-cm883061"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Advanced Gastric Cancer"|"2017-11-28T13:25:00.000+00:00"|"DARMSTADT, Germany and NEW YORK , Nov. 28, 2017 /PRNewswire/ -- Not intended for UK-based media   Pivotal Phase III   Javelin   trial investigating avelumab as third-line treatment for patients with unresectable, ..."|"https://finance.yahoo.com/news/merck-pfizer-phase-iii-javelin-132500995.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"BRIEF-Zhejiang Hisun Pharmaceutical's share trade to resume after Pfizer exited China JV"|"2017-11-28T13:16:43.000+00:00"|"Nov 28 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd : * SAYS SHARE TRADE TO RESUME ON NOV 29 AFTER PFIZER EXITED CHINA JOINT VENTURE WITH THE COMPANY Source text in Chinese: http://bit.ly/2iZ534b Further ..."|"https://finance.yahoo.com/news/brief-zhejiang-hisun-pharmaceuticals-share-131643103.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer, Germany's Merck cancer treatment trial misses primary endpoint"|"2017-11-28T13:12:36.000+00:00"|"Pfizer Inc. and German-based Merck KGaA said Tuesday a phase 3 trial of a cancer treatment did not meet its primary endpoint of superior overall survival. Pfizer's stock slipped 0.9% in premarket trade. ..."|"http://finance.yahoo.com/r/48fa4666-5051-320d-ab50-836bebd5437c/Story.aspx?guid=73DFA7BF-4AF5-4060-B858-2F56708805AA&siteid=yhoof2&yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Merck KGaA, Pfizer's avelumab misses goal in gastric cancer trial"|"2017-11-28T13:12:24.000+00:00"|"Germany's Merck KGaA said on Tuesday that its cancer immunotherapy avelumab, jointly developed with Pfizer, failed to improve overall survival compared with standard chemotherapy in a late-stage study ..."|"https://finance.yahoo.com/news/merck-kgaa-pfizers-avelumab-misses-131224988.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients with Pre-Treated Advanced Gastric Cancer"|"2017-11-28T13:10:00.000+00:00"|"DARMSTADT, Germany and NEW YORK , November 28, 2017 /PRNewswire/ -- N ot intended for UK-based media   Pivotal Phase III J avelin trial investigating avelumab as third-line treatment for patients with ..."|"https://finance.yahoo.com/news/merck-kgaa-darmstadt-germany-pfizer-131000336.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Merck, Pfizer: Phase III Javelin Gastric 300 Trial Did Not Meet Primary Endpoint"|"2017-11-28T08:19:00.000+00:00"|"Merck, Pfizer: Phase III Javelin Gastric 300 Trial Did Not Meet Primary Endpoint"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g5ukdsP84Kk/merck-pfizer-phase-iii-javelin-gastric-300-trial-did-not-meet-primary-endpoint-20171128-00504"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Cramer's biggest investing mistakes"|"2017-11-28T00:10:00.000+00:00"|"Jim Cramer opened up the lesson book and shared his top blunders made on Wall Street."|"https://finance.yahoo.com/video/cramers-biggest-investing-mistakes-001000954.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Cramer admits his biggest investing mistakes"|"2017-11-28T00:00:00.000+00:00"|"Jim Cramer opened up the lesson book and shared his top blunders made on Wall Street."|"https://finance.yahoo.com/video/cramer-admits-biggest-investing-mistakes-000000969.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Cramer admits his biggest investing mistakes"|"2017-11-27T23:45:46.000+00:00"|"Jim Cramer opened up the lesson book and shared his top blunders made on Wall Street."|"http://finance.yahoo.com/r/7d83f99a-5ca5-3926-8e8c-f9a3918cb7b6/104863990?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104863990&yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Chip Stocks Drag Nasdaq Lower"|"2017-11-27T23:06:51.000+00:00"|"The U S stock market started the day trading in positive territory with the Dow Jones Industrial Average DJIA S amp P 500 Index SPX and Nasdaq Composite IXIC all carving out new highs Retail stocks were one of the driving forces behind the early action as traders"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bhcScvsC6e8/chip-stocks-drag-nasdaq-lower-cm882858"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"One Put, One Call Option To Know About for Pfizer"|"2017-11-27T18:08:32.000+00:00"|"Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the January 2019 expiration for PFE The put"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JSIiNiyjF9Q/one-put-one-call-option-to-know-about-for-pfizer-cm882638"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"XLV, SZK: Big ETF Outflows"|"2017-11-27T17:10:45.000+00:00"|"Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel the biggest outflow was seen in the Health Care Select Sector SPDR Fund XLV where 4 600 000 units were destroyed or a 2 2 decrease week over week Among the largest underlying"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B_oqnN4y-G0/xlv-szk-big-etf-outflows-cm882560"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"SPDR Portfolio Total Stock Market ETF Experiences Big Inflow"|"2017-11-27T17:07:20.000+00:00"|"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR Portfolio Total Stock Market ETF Symbol SPTM where we have detected an approximate 56 7 million dollar inflow that s a 9 3 increase week over week"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_RDYvbq0NAU/spdr-portfolio-total-stock-market-etf-experiences-big-inflow-cm882533"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Why Pfizer, Applied Materials And Three Other GARP Stocks Look Attractive"|"2017-11-27T15:37:00.000+00:00"|"Because investors these days thirst for growth, and because the market as a whole is expensive, this may be a good time for the 'growth at a reasonable price' approach to selecting stocks."|"http://finance.yahoo.com/r/e09107f4-1526-3ed6-b32b-7d9c096c7744/why-pfizer-applied-materials-and-three-other-garp-stocks-look-attractive?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Investor Expectations to Drive Momentum within Intel, Pfizer, CenturyLink, Marathon Oil, Applied Materials, and AK Steel Holding — Discovering Underlying Factors of Influence"|"2017-11-27T13:10:00.000+00:00"|"NEW YORK, Nov. 27, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Intel ..."|"https://finance.yahoo.com/news/investor-expectations-drive-momentum-within-131000089.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"3 Companies Competing to Gain Lead in Ovarian Cancer Market"|"2017-11-24T18:57:10.000+00:00"|"Until 2014 very few options were available to treat ovarian cancer and these primarily included chemotherapy radiation or surgery Though effective these treatments had many side effects While chemotherapy can destroy a patient s immune system radiation kills normal cells along with"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Oa5e-len1E8/3-companies-competing-to-gain-lead-in-ovarian-cancer-market-cm882119"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"What’s Johnson & Johnson’s Valuation?"|"2017-11-24T18:30:56.000+00:00"|"As of November 21, 2017, Johnson & Johnson was trading at a forward PE multiple of ~17.6x as compared to the industry average of 16.2x."|"http://finance.yahoo.com/r/0563826f-7f48-3389-95c9-74cff70e0514/whats-johnson-johnsons-valuation-2?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Health Care Sector Update for 11/24/2017: JNJ, PFE, ABT, MRK, AMGN, TEVA, NKTR"|"2017-11-24T14:36:27.000+00:00"|"Top Health Care Stocks Top Health Care Stocks JNJ flatJNJ flat PFE flatPFE flat ABT 0 02 ABT 0 02 MRK flatMRK flat AMGN flatAMGN flat Health care shares were mostly flat in pre market trading Friday Health care shares were mostly flat inpre market trading Friday In sector"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9RYDcS829Q8/health-care-sector-update-for-11242017-jnj-pfe-abt-mrk-amgn-teva-nktr-cm881957"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for November 27, 2017"|"2017-11-24T14:16:16.000+00:00"|"Johnson amp Johnson JNJ will begin trading ex dividend on November 27 2017 A cash dividend payment of 0 84 per share is scheduled to be paid on December 12 2017 Shareholders who purchased JNJ prior to the ex dividend date are eligible for the cash dividend payment This marks the"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Th7097lxLKk/johnson-johnson-jnj-ex-dividend-date-scheduled-for-november-27-2017-cm881936"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Value-Adding Dividend Stocks To Buy Now"|"2017-11-24T13:02:22.000+00:00"|"A great investment for income investors with a long time horizon is in dividend-paying companies like Pfizer. Dividend stocks are a safe bet to increase your portfolio value as theyRead More..."|"https://finance.yahoo.com/news/value-adding-dividend-stocks-buy-130222873.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Teva on the Street: Analyst Recommendations in November 2017"|"2017-11-23T15:32:14.000+00:00"|"Teva is actively making progress toward divestiture opportunities. In November 2017, it divested Paragard to Cooper Surgical for $1.1 billion."|"http://finance.yahoo.com/r/caf2badf-1dab-363d-ba13-93e5e0f9aa0b/analysts-recommendations-teva-pharmaceuticals-november-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Top 10 Largest Pharmaceutical Companies By Revenue in 2017"|"2017-11-23T14:00:14.000+00:00"|"The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced manufacturing and R&D facilities. Though their businesses are recession-proof, a huge portion of their expenses has to be allocated to research and development to stay ahead of the competition. Medicine has […]"|"http://finance.yahoo.com/r/ea12e34a-6fb5-3697-a804-dd6bf63228bc/top-10-largest-pharmaceutical-companies-by-revenue-in-2017-611551?yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"See what the IHS Markit Score report has to say about Pfizer Inc."|"2017-11-23T13:00:26.000+00:00"|"Pfizer Inc NYSE:PFE"|"https://finance.yahoo.com/news/see-ihs-markit-score-report-130026045.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Levin Capital Strategies, L.p. Buys DowDuPont Inc, Walt Disney Co, Treehouse Foods Inc, Sells ..."|"2017-11-22T19:54:48.000+00:00"|"Levin Capital Strategies L p New Purchases DWDP STX MRK NLSN NYRT TPGE U HUBB MAC TISI JACK Added Positions DIS THS AGN GM CB PF UTX ETN TSN BAC Reduced Positions GE M INTC CVS AXP MS C COT AXL BKU Sold Out DD ZBH"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VmdW439Ip80/levin-capital-strategies-lp-buys-dowdupont-inc-walt-disney-co-treehouse-foods-inc-sells-cm881601"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"How Teva’s Generic Medicines Business Is Positioned after 3Q17"|"2017-11-22T19:30:10.000+00:00"|"Teva's Generic Medicine segment generated 3Q17 revenues of $3.0 billion, which was ~8% higher YoY (year-over-year) but ~2% lower QoQ (quarter-over-quarter)."|"http://finance.yahoo.com/r/0d1e92da-07f8-3dec-b8f5-73b9b82a3ebb/teva-pharmaceuticals-generic-medicine-franchise-positioned-3q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"J&J & Glaxo Get FDA Approval for First Two-Drug HIV Regimen"|"2017-11-22T17:03:00.000+00:00"|"Johnson amp Johnson JNJ and partner GlaxoSmithKline GSK announced FDA approval for Juluca a two drug complete regimen of Tivicay rilpivirine and Edurant dolutegravir as a single tablet for the treatment of HIV 1 infection Tivicay a novel investigational integrase strand transfer"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2FMkezcsLPQ/jj-glaxo-get-fda-approval-for-first-two-drug-hiv-regimen-cm881424"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Stock Market News For Nov 22, 2017"|"2017-11-22T17:02:17.000+00:00"|"Benchmarks finished in the green on Tuesday following gains in the technology and healthcare sectors Increase in Apple s shares boosted the broader tech sector while healthcare stocks rallied upward after Medtronic posted strong quarterly performance and reiterated its fiscal 2018 revenue and"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZRA3wfBpz20/stock-market-news-for-nov-22-2017-cm881390"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"The Outlook For Merck’s Anti-Infectives Drug Business"|"2017-11-22T14:55:43.000+00:00"|"Anti infective drugs are important to Merck 160 MRK constituting nearly 35 of its value according to our estimates Most of this value can be attributed to four drugs Gardasil Zepatier Isentress and Proquad MMR II Varivax with the rest coming from the phase 3 pipeline and"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bSIc8Ud7q24/the-outlook-for-mercks-anti-infectives-drug-business-cm881275"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Health Care Sector Update for 11/22/2017: JNJ, PFE, ABT, MRK, AMGN, EXEL, PBMD, SSY"|"2017-11-22T14:35:42.000+00:00"|"Top Health Care Stocks Top Health Care Stocks JNJ 0 1 JNJ 0 1 PFE 0 1 PFE 0 1 ABT flatABT flat MRK 0 3 MRK 0 3 AMGN flatAMGN flat Health care shares were mixed in pre market trading Wednesday Health care shares were mixed inpre market trading Wednesday In sector"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pJrLgznKDCM/health-care-sector-update-for-11222017-jnj-pfe-abt-mrk-amgn-exel-pbmd-ssy-cm881274"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"First 2-drug HIV Regimen Gets FDA Nod, Starpharma Shines, ARDX Drops RDX7675"|"2017-11-22T01:19:00.000+00:00"|"First 2-drug HIV Regimen Gets FDA Nod, Starpharma Shines, ARDX Drops RDX7675"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0IpPt3YzHt4/first-2drug-hiv-regimen-gets-fda-nod-starpharma-shines-ardx-drops-rdx7675-20171122-00017"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Juluca® (dolutegravir and rilpivirine) approved in US as first 2-drug regimen, once-daily, single pill - a complete regimen for the maintenance treatment of virologically suppressed HIV-1 infection"|"2017-11-22T00:45:00.000+00:00"|"LONDON , Nov. 21, 2017 /PRNewswire/ -- ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that ..."|"https://finance.yahoo.com/news/juluca-dolutegravir-rilpivirine-approved-us-004500889.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"8 Bitcoin Stocks That You Won’t Lose Your Shirt Over"|"2017-11-21T21:37:12.000+00:00"|"InvestorPlace Stock Market News Stock Advice amp Trading Tips Bitcoin may not have the trust of Wall Street institutions just yet but millennials are all in Blockchain Capital 160 recently conducted a study 160 of 2 000 millennials aged 18 34 and asked them to 160 make"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s1Pmi9nbFAM/8-bitcoin-stocks-that-you-wont-lose-your-shirt-over-cm881058"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"ViiV Healthcare : FDA Okays First Two-drug Regimen For Certain Patients With HIV"|"2017-11-21T20:13:00.000+00:00"|"ViiV Healthcare : FDA Okays First Two-drug Regimen For Certain Patients With HIV"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/17f0UDfl4G8/viiv-healthcare--fda-okays-first-twodrug-regimen-for-certain-patients-with-hiv-20171121-01306"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Patent Expiry, Competition Will Continue To Weigh On Bristol-Myers Squibb's Virology Portfolio"|"2017-11-21T17:33:02.000+00:00"|"Bristol Myers Squibb s 160 BMY virology segment which primarily consists of Reyataz Sustiva 160 Baraclude and Hepatitis C franchise accounts for around 10 of the company s value according to our estimates The company derives most of its value from oncology drugs which we believe"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TZgGhHUVyWA/patent-expiry-competition-will-continue-to-weigh-on-bristol-myers-squibbs-virology-portfolio-cm880823"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"8 Bitcoin Stocks That You Won’t Lose Your Shirt Over"|"2017-11-21T16:59:45.000+00:00"|"Bitcoin may not have the trust of Wall Street institutions just yet, but millennials are all in.  Blockchain Capital recently conducted a study of 2,000 millennials (aged 18-34) and asked them to make a theoretical choice between owning $1,000 in bonds or stocks and $1,000 in bitcoin.  It seems millennials are laughing all the way to the decentralized blockchain."|"https://finance.yahoo.com/news/8-bitcoin-stocks-won-t-165945697.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Health Care Sector Update for 11/21/2017: JNJ, PFE, ABT, MRK, AMGN, ARDX, MDT, NVO"|"2017-11-21T14:34:05.000+00:00"|"Top Health Care Stocks Top Health Care Stocks JNJ 0 3 JNJ 0 3 PFE 0 1 PFE 0 1 ABT flatABT flat MRK flatMRK flat AMGN 0 1 AMGN 0 1 Health care shares were mixed in pre market trading Tuesday Health care shares were mixed inpre market trading Tuesday In sector news"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/54CS6NP1SYA/health-care-sector-update-for-11212017-jnj-pfe-abt-mrk-amgn-ardx-mdt-nvo-cm880599"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Is Merck & Co. Inc. a Buy?"|"2017-11-21T13:39:04.000+00:00"|"If 2017 ended right now it would be the worst year for Merck amp Co NYSE MRK stock since the financial crisis of 2008 There are still several weeks remaining before the year ends of course but the big pharma stock is down at a time when most of its peers are performing"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DJJprekZJrc/is-merck-co-inc-a-buy-cm880507"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"November Pharma And Biotech Dividend Stocks To Look Out For"|"2017-11-21T13:03:25.000+00:00"|"Regularly affected by the ever-changing regulatory environment, the pharmaceutical and biotech industry is not one for producing the most stable cash flow. Thus, investors don’t usually associate this industry withRead More..."|"https://finance.yahoo.com/news/november-pharma-biotech-dividend-stocks-130325144.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"See what the IHS Markit Score report has to say about Pfizer Inc."|"2017-11-21T13:00:21.000+00:00"|"Pfizer Inc NYSE:PFE"|"https://finance.yahoo.com/news/see-ihs-markit-score-report-130021331.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Is Merck & Co. Inc. a Buy?"|"2017-11-21T11:12:00.000+00:00"|"Merck just might be poised for a rebound. But is the stock a smart long-term pick?"|"https://finance.yahoo.com/news/merck-co-inc-buy-111200764.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Drug firm Concordia overcharged Britain's health service with 6,000 percent price rise"|"2017-11-21T10:38:42.000+00:00"|"Drug company Concordia overcharged Britain's health service millions of pounds for an essential thyroid drug by abusing its position as the only supplier, the country's Competition and Markets Authority said on Tuesday.  The National Health Service spent 34 million pounds on liothyronine tablets last year, up from 600,000 pounds a decade ago, after Concordia increased the price per pack by almost 6,000 percent from 4.46 pounds to 258.19 pounds.  CMA Chief Executive Andrea Coscelli said: \"Pharmaceutical companies which abuse their position and overcharge for drugs are forcing the NHS - and the UK taxpayer - to pay over the odds for important medical treatments."|"https://finance.yahoo.com/news/britain-says-canadas-concordia-overcharging-095518761.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Drug firm Concordia overcharged Britain's health service with 6,000 pct price rise"|"2017-11-21T10:36:09.000+00:00"|"Drug company Concordia  overcharged Britain's health service millions of pounds for an  essential thyroid drug by abusing its position as the only  supplier, the country's Competition and Markets Authority said  on Tuesday.  The National Health Service spent 34 million pounds ($45  million) on liothyronine tablets last year, up from 600,000  pounds a decade ago, after Concordia increased the price per  pack by almost 6,000 percent from 4.46 pounds to 258.19 pounds.  CMA Chief Executive Andrea Coscelli said: \"Pharmaceutical  companies which abuse their position and overcharge for drugs  are forcing the NHS - and the UK taxpayer - to pay over the odds  for important medical treatments."|"https://finance.yahoo.com/news/drug-firm-concordia-overcharged-britains-103609018.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Britain says Canada's Concordia overcharging health service for thyroid drug"|"2017-11-21T09:47:32.000+00:00"|"Drug company Concordia  overcharged Britain's health service millions of pounds for an  essential thyroid drug by abusing its position as the only  supplier, the country's Competition and Markets Authority said  on Tuesday.  The National Health Service spent 34 million pounds ($45  million) on liothyronine tablets last year, up from 600,000  pounds a decade ago, after Concordia increased the price per  pack by almost 6,000 percent from 4.46 pounds to 258.19 pounds.  CMA Chief Executive Andrea Coscelli said: \"Pharmaceutical  companies which abuse their position and overcharge for drugs  are forcing the NHS - and the UK taxpayer - to pay over the odds  for important medical treatments."|"https://finance.yahoo.com/news/britain-says-canadas-concordia-overcharging-094732563.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Roche Sues Pfizer to Bar Biosimilar of Cancer Drug Herceptin"|"2017-11-20T23:41:39.000+00:00"|"Roche Holding AG, facing pressure in Europe as cheaper biosimilars of its three biggest cancer medicines chew away at its revenue, sued to block Pfizer Inc. from selling a copy of its breast-cancer drug ..."|"http://finance.yahoo.com/r/5cc3d2ff-d8cb-3fd7-8ede-7c08dcf16ea1/roche-sues-pfizer-to-block-biosimilar-of-cancer-drug-herceptin?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Stay away from big pharma?"|"2017-11-20T22:26:00.000+00:00"|"Carter Worth, Cornerstone Macro, discusses what stocks to avoid in the pharmaceuticals sector. The “Fast Money” traders weigh in."|"https://finance.yahoo.com/video/stay-away-big-pharma-222600312.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"After Hours Most Active for Nov 20, 2017 :  ACM, QQQ, BAC, LC, EUFN, PFE, WFC, T, URBN, FITB, GILD, AAPL"|"2017-11-20T22:06:24.000+00:00"|"The NASDAQ 100 After Hours Indicator is down 78 to 6 307 83 The total After hours volume is currently 45 025 833 shares traded The following are the most active stocks for the after hours session AECOM ACM is unchanged at 36 00 with 6 917 362 shares traded"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8RxwhbLoCjI/after-hours-most-active-for-nov-20-2017-acm-qqq-bac-lc-eufn-pfe-wfc-t-urbn-fitb-gild-aapl-cm880374"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Interesting December Stock Options for PFE"|"2017-11-20T19:09:08.000+00:00"|"Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the December expiration for PFE The put contract"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c0YsLxFhcf8/interesting-december-stock-options-for-pfe-cm880248"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"ETFs with exposure to Pfizer Inc. : November 20, 2017"|"2017-11-20T18:04:46.000+00:00"|"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pfizer Inc. Here are 5 ETFs with the largest exposure to PFE-US. Comparing the performance and risk of Pfizer Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"|"http://finance.yahoo.com/r/2249c515-0058-3be3-bf3c-15d9672bb33a/etfs-with-exposure-to-pfizer-inc-november-20-2017?yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Amgen (AMGN) Unveils Auto Injector Device for Enbrel in US"|"2017-11-20T17:14:08.000+00:00"|"Amgen Inc AMGN announced the launch of its Enbrel Mini with AutoTouch a new auto injector device for Enbrel in the United States The Enbrel Mini single dose prefilled cartridges used with the AutoTouch reusable autoinjector device provide an additional administration option for"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/92eJVpgbuo8/amgen-amgn-unveils-auto-injector-device-for-enbrel-in-us-cm880097"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Trump may eliminate health provision in tax bill"|"2017-11-20T16:40:19.000+00:00"|"Republicans are willing to do just about anything to push tax reform through Congress. Even if that means dropping the repeal of the Affordable Care Act mandate, which requires that most people have health insurance or pay a penalty. Yahoo Finance’s Alexis Christoforous and Myles Udland figure the next move the GOP may take."|"https://finance.yahoo.com/video/trump-may-eliminate-health-provision-164019700.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Health Care Sector Update for 11/20/2017: JNJ, PFE, ABT, MRK, AMGN, DBVT, EGLT, ACOR"|"2017-11-20T14:06:34.000+00:00"|"Top Health Care Stocks Top Health Care Stocks JNJ 0 01 JNJ 0 01 PFE 0 6 PFE 0 6 ABT 0 2 ABT 0 2 MRK 2 1 MRK 2 1 AMGN flatAMGN flat Health care shares were mostly lower in pre market trading Monday Health care shares were mostly lower inpre market trading Monday In"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sqr0erXiT68/health-care-sector-update-for-11202017-jnj-pfe-abt-mrk-amgn-dbvt-eglt-acor-cm879839"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"ImmunoPrecise Realigns Senior Management"|"2017-11-20T13:30:00.000+00:00"|"ImmunoPrecise Realigns Senior Management"|"https://finance.yahoo.com/news/immunoprecise-realigns-senior-management-133000996.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"See what the IHS Markit Score report has to say about Pfizer Inc."|"2017-11-20T13:00:20.000+00:00"|"Pfizer Inc NYSE:PFE"|"https://finance.yahoo.com/news/see-ihs-markit-score-report-130020026.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Tax reform could come before 2018, so a strategist says buy these 2 stocks"|"2017-11-18T19:58:19.000+00:00"|"According to one strategist, there will be two clear winners of the current GOP tax plan."|"http://finance.yahoo.com/r/9e2c9534-0c00-3d9f-be3b-0a0c637ea80c/104850534?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104850534&yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Tax reform could come before 2018, so a strategist says buy these 2 stocks"|"2017-11-18T19:58:19.000+00:00"|"According to one strategist, there will be two clear winners of the current GOP tax plan."|"https://finance.yahoo.com/news/tax-reform-could-come-2018-195819514.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Nevada refusing Pfizer demand for return of execution drugs"|"2017-11-18T01:26:03.000+00:00"|"A Nevada prisons official said Friday the state is refusing pharmaceutical company Pfizer's demand to return a drug it manufactured and not use it in a planned lethal injection execution."|"http://finance.yahoo.com/r/0ddfef2b-4b29-3501-82eb-8df870c23a19/pfizer-tells-nebraska-not-drugs-191840391.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Nevada wants to use untried execution drugs that pose risks"|"2017-11-18T01:16:39.000+00:00"|"LAS VEGAS (AP) — For Nevada's first execution in more than a decade, state officials are turning to a never-before-tried combination of drugs, including a powerful painkiller that is fueling much of the nation's opioid epidemic and a paralyzing drug that could mask any signs of trouble."|"http://finance.yahoo.com/r/57fff65f-ae2c-33d6-8190-9ebb044200e1/nevada-seeks-untried-execution-drugs-including-opioid-083525332.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Nevada wants to use untried execution drugs that pose risks"|"2017-11-18T01:16:21.000+00:00"|"For Nevada's first execution in more than a decade, state officials are turning to a never-before-tried combination of drugs, including a powerful painkiller that is fueling much of the nation's opioid ..."|"https://finance.yahoo.com/news/nevada-seeks-untried-execution-drugs-including-opioid-083525332.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"The Latest: Nevada won't return execution drug to Pfizer"|"2017-11-18T00:13:02.000+00:00"|"The Latest on a pharmaceutical company's demand that states not use drugs it made for lethal injection executions (all times local): 5:30 p.m. An official says Nevada doesn't plan to return one of the ..."|"https://finance.yahoo.com/news/latest-nevada-wont-return-execution-235521870.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer's Cancer Drug Sutent Gets FDA Nod for Label Expansion"|"2017-11-18T00:03:40.000+00:00"|"Pfizer Inc PFE announced that the FDA has approved a label expansion for its cancer drug Sutent sunitinib malate With this latest approval Sutent s label has been expanded as an adjuvant treatment of adult patients at high risk of recurrent renal cell carcinoma RCC following"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3x4TXMBj5KU/pfizers-cancer-drug-sutent-gets-fda-nod-for-label-expansion-cm879521"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"The Latest: Nevada won't return execution drug to Pfizer"|"2017-11-17T23:55:07.000+00:00"|"LINCOLN, Neb. (AP) — The Latest on a pharmaceutical company's demand that states not use drugs it made for lethal injection executions (all times local):"|"http://finance.yahoo.com/r/62739af5-663b-3731-bf44-a84b4702c8b5/latest-nevada-wont-return-execution-235521870.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer&apos;s Cancer Drug Sutent Gets FDA Nod for Label Expansion"|"2017-11-17T22:09:10.000+00:00"|"Pfizer (PFE) secures an FDA approval for Sutent&apos;s label expansion as an adjuvant treatment of recurrent renal cell carcinoma."|"https://finance.yahoo.com/news/pfizer-apos-cancer-drug-sutent-220910394.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Why It’s Time to Put Pfizer Inc. Stock on Your Watchlist"|"2017-11-17T20:07:24.000+00:00"|"InvestorPlace Stock Market News Stock Advice amp Trading Tips Ever since its cholesterol fighting drug Lipitor lost the crux of its patent protection back in 2011 Pfizer Inc NYSE PFE investors have approached PFE stock with caution And perhaps for"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LcC5ByaM288/why-its-time-to-put-pfizer-inc-stock-on-your-watchlist-cm879431"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Cancer Space Update: Label Expansion for Three Major Drugs"|"2017-11-17T17:08:59.000+00:00"|"With a busy earnings season almost coming to an end after an impressive run we are again focused on latest cancer updates happening every week The week gone by saw three cancer drugs receiving FDA approval for new indications Roche Holding AG s RHHBY Gazyva Pfizer Inc s PFE Sutent"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sM9cG1k7Pm0/cancer-space-update-label-expansion-for-three-major-drugs-cm879224"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Notable ETF Inflow Detected - XLV, JNJ, PFE, ABBV"|"2017-11-17T17:05:47.000+00:00"|"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Health Care Select Sector SPDR Fund Symbol XLV where we have detected an approximate 142 7 million dollar inflow that s a 0 8 increase week over week"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zNkUgGMNUZw/notable-etf-inflow-detected-xlv-jnj-pfe-abbv-cm879220"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Novartis on the Street: Analysts’ Recommendations in November"|"2017-11-17T15:30:19.000+00:00"|"Of the three analysts tracking Novartis in November 2017, one recommends a “strong buy,” while two recommend a “hold.\""|"http://finance.yahoo.com/r/e66188f5-7b65-3c90-8f91-070ec4bfbc74/novartis-street-analysts-recommendations-november?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Why It’s Time to Put Pfizer Inc. Stock on Your Watchlist"|"2017-11-17T15:12:28.000+00:00"|"Ever since its cholesterol-fighting drug Lipitor lost the crux of its patent protection back in 2011, Pfizer Inc. (NYSE:PFE) investors have approached PFE stock with caution.  Early this week, Purkiss made a point of saying sales of Ibrance is being underestimated, suggesting that rather than achieving just a little less than $7 billion in revenue in 2023, it could actually produce nearly $13-billion worth of business that year as its approved uses were expanded and caregivers saw its efficacy."|"https://finance.yahoo.com/news/why-time-put-pfizer-inc-151228917.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Cancer Space Update: Label Expansion for Three Major Drugs"|"2017-11-17T14:53:02.000+00:00"|"This week three major drugs received approval for label expansion in new indications. Moreover, a small biotech launched its first drug as a treatment for kidney cancer."|"https://finance.yahoo.com/news/cancer-space-label-expansion-three-145302710.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"These 3 Stocks Might as Well Not Even Be in the Dow Jones Industrials"|"2017-11-17T12:07:33.000+00:00"|"The Dow Jones Industrials DJINDICES DJI have had a strong 2017 adding to their gains over the past nine years and rewarding those investors who stuck with the stock market in the aftermath of the financial crisis Yet even though the Dow has 30 stocks that are among the"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MlIGy6s9Qdc/these-3-stocks-might-as-well-not-even-be-in-the-dow-jones-industrials-cm878976"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"These 3 Stocks Might as Well Not Even Be in the Dow Jones Industrials"|"2017-11-17T11:02:00.000+00:00"|"Find out why these huge companies have almost no influence on the average."|"https://finance.yahoo.com/news/3-stocks-might-well-not-110200560.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"FDA Nod For Label Expansion Of Sutent, Egalet Flies, Double Blessing For Roche"|"2017-11-17T00:13:00.000+00:00"|"FDA Nod For Label Expansion Of Sutent, Egalet Flies, Double Blessing For Roche"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sjCZ5UWDWKo/fda-nod-for-label-expansion-of-sutent-egalet-flies-double-blessing-for-roche-20171117-00001"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer: FDA Expands Approval Of Sutent To Reduce Risk Of Kidney Cancer Returning"|"2017-11-16T23:26:00.000+00:00"|"Pfizer: FDA Expands Approval Of Sutent To Reduce Risk Of Kidney Cancer Returning"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kiPAeIVi2OE/pfizer-fda-expands-approval-of-sutent-to-reduce-risk-of-kidney-cancer-returning-20171116-01570"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Partner Fund Management, L.P. Buys Portola Pharmaceuticals Inc, Centene Corp, Allergan PLC, ..."|"2017-11-16T23:03:19.000+00:00"|"Partner Fund Management L P New Purchases CNC AGNPRA SPY PFE NFLX XBI SNNA IWM INGN SWKS Added Positions PTLA JUNO FB CRM JD EW GOOGL ATVI ABT ACOR Reduced Positions KITE BABA V HUM PBYI DXC CLVS MDCO MOH NOW Sold Out"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/liwFbzUOrJ0/partner-fund-management-lp-buys-portola-pharmaceuticals-inc-centene-corp-allergan-plc-cm878889"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer Receives FDA Approval for SUTENT® (sunitinib malate) as First and Only Adjuvant Treatment for Adult Patients at High Risk of Recurrent Renal Cell Carcinoma"|"2017-11-16T21:58:00.000+00:00"|"Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved a new indication expanding the use of SUTENT® to include the adjuvant treatment of adult patients at high risk of recurrent renal cell carcinoma following nephrectomy ."|"https://finance.yahoo.com/news/pfizer-receives-fda-approval-sutent-215800996.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Charles Brandes Buys YPF SA, Cardinal Health Inc, HCA Healthcare Inc, Sells State Street ..."|"2017-11-16T19:03:56.000+00:00"|"Charles Brandes New Purchases WPPGY OMC AAP TARO PLT Added Positions YPF HCA CAH FCN APA CHK AVAL INFY FII OMI Reduced Positions STT AMX PNC MSFT C SNY EXC GSK BP CX Sold Out TSU BW AAN ARCO DEO OSB KB PM MGA CO"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/naNPMw4ZJWw/charles-brandes-buys-ypf-sa-cardinal-health-inc-hca-healthcare-inc-sells-state-street-cm878672"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Obamacare enrollment soars in first 11 days"|"2017-11-16T16:52:56.000+00:00"|"Open enrollment is going strong for the Affordable Care Act. Almost 1.5M people have signed up for Obamacare during the first two weeks of open enrollment. That's up a whopping 46% compared to the same time last year. Yahoo Finance’s Alexis Christoforous and Myles Udland figure out what’s behind the sharp increase."|"https://finance.yahoo.com/video/obamacare-enrollment-soars-first-11-165256142.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"AstraZeneca’s Valuation after 3Q17 Earnings"|"2017-11-16T16:26:22.000+00:00"|"In 3Q17, AstraZeneca reported EPS of $0.56 on revenues of $6.2 billion compared to estimates of $0.71 for EPS on revenues of $6 billion."|"http://finance.yahoo.com/r/d56bd202-673d-3aa0-9fef-330ec331714e/astrazenecas-valuation-3q17-earnings?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"AstraZeneca's Faslodex Gets FDA Nod for Use With Verzenio"|"2017-11-16T16:10:01.000+00:00"|"AstraZeneca plc AZN announced that the FDA has granted approval to a new indication for its breast cancer drug Faslodex The label of Faslodex will now be expanded to include combination use with Eli Lilly s LLY new CDK4 6 inhibitor Verzenio abemaciclib to treat women with HR HER2"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZFfYduVANrA/astrazenecas-faslodex-gets-fda-nod-for-use-with-verzenio-cm878439"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"See what the IHS Markit Score report has to say about Pfizer Inc."|"2017-11-16T13:00:29.000+00:00"|"Pfizer Inc NYSE:PFE"|"https://finance.yahoo.com/news/see-ihs-markit-score-report-130029398.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Which Products Are Driving Revenues for Antares Pharma in 2017?"|"2017-11-16T12:32:52.000+00:00"|"Sumatriptan is the only injectable triptan approved for use in the US. The product achieved a market share of 26.0% in 2Q17, up from 21.0% in 1Q17."|"http://finance.yahoo.com/r/0f9b42a0-c290-3379-a173-11adedf27b6b/products-driving-revenues-antares-pharma-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Two Sigma Advisers, Llc Buys DowDuPont Inc, Pfizer Inc, Caterpillar Inc, Sells E.I. ..."|"2017-11-16T11:18:31.000+00:00"|"Two Sigma Advisers Llc New Purchases DWDP BIDU BHGE ANTM MA OXY SHPG TXN CDK PSA Added Positions PFE CAT MDLZ TGT ISRG INTC MO MON ROST UNP Reduced Positions C CI CSCO CMG FB WMT CVS JNJ JD PCLN Sold Out DD ARMK MGM"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u4zSeMiECr8/two-sigma-advisers-llc-buys-dowdupont-inc-pfizer-inc-caterpillar-inc-sells-ei-cm878249"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Avalon Advisors, Llc Buys DowDuPont Inc, Berkshire Hathaway Inc, Chevron Corp, Sells ..."|"2017-11-16T07:18:34.000+00:00"|"Avalon Advisors Llc New Purchases DWDP BRK A IRM OXY LYB CL CTAS AMD PVH CVS Added Positions CVX MS WMT KSU GLD INTC CNC KO JPM PG Reduced Positions XOM IBM ABT MSFT AMZN WFC PAGP GS KHC KMB Sold Out WBA K SNA NUE"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hs1j-yNPHqo/avalon-advisors-llc-buys-dowdupont-inc-berkshire-hathaway-inc-chevron-corp-sells-cm878227"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer, Novartis agree UK price cuts for new breast cancer drugs"|"2017-11-16T00:01:00.000+00:00"|"Pfizer and Novartis  have agreed price cuts for their rival breast cancer  drugs Ibrance and Kisqali to ensure they can be used routinely  within Britain's state-funded health service.  Both are oral drugs, given in concert with hormonal  therapies, that inhibit two proteins called CDK 4 and 6.  A third CDK 4/6 drug from Eli Lilly is also licensed  in the United States but not yet in Europe."|"https://finance.yahoo.com/news/pfizer-novartis-agree-uk-price-000100471.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"How to Invest in Companies That Place Women in Senior Leadership Roles"|"2017-11-15T23:23:55.000+00:00"|"A recent study by Korn Ferry International NYSE KFY entitled What Makes Women Different turned up a number of intriguing facts about gender diversity in corporate America For example 160 female CEOs tend to be slightly older than male CEOs because it takes women"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vv2dvu4ikqk/how-to-invest-in-companies-that-place-women-in-senior-leadership-roles-cm878163"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Despite Valeant Improvement, VRX Stock Price Is Still Too High"|"2017-11-15T18:56:59.000+00:00"|"New CEO Joe Papa has done a nice job in his efforts to turn around Valeant Pharmaceuticals Intl Inc (NYSE:VRX).  Generic drugmakers have been taken to the woodshed, with Teva Pharmaceutical Industries Ltd (NYSE:TEVA) down 67% year-to-date and Mallinckrodt PLC (NYSE:MNK) off 56%."|"https://finance.yahoo.com/news/despite-valeant-improvement-vrx-stock-185659417.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"GOP tax plan takes aim at Obamacare"|"2017-11-15T16:10:00.000+00:00"|"Senate Republicans have wanted to kill the Obamacare individual mandate for a long time and now they're looking to do it as part of their tax reform proposal.  Senate Majority Leader Mitch McConnell says the GOP tax plan will now include a provision to repeal the Obamacare mandate, which requires everyone to have health insurance. Yahoo Finance’s Alexis Christoforous and Rick Newman breakdown what this means for Americans."|"https://finance.yahoo.com/video/gop-tax-plan-takes-aim-161010494.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"3 Value Stocks Perfect for Retirement"|"2017-11-15T16:04:16.000+00:00"|"Many savvy investors know they ll need steady income generating stocks in retirement but finding companies that can do that and that are priced under their potential is not always easy That s why three Motley Fool writers have put together a short list of value stocks that"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9g4TUoILmY4/3-value-stocks-perfect-for-retirement-cm877713"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Why Pfizer Inc (PFE) Could Be A Buy"|"2017-11-15T15:57:15.000+00:00"|"Let’s talk about the popular Pfizer Inc (NYSE:PFE). The company’s shares received a lot of attention from a substantial price movement on the NYSE in the over the last fewRead More..."|"https://finance.yahoo.com/news/why-pfizer-inc-pfe-could-155715182.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"3 Value Stocks Perfect for Retirement"|"2017-11-15T14:45:00.000+00:00"|"Don&apos;t judge these stocks at first glance."|"https://finance.yahoo.com/news/3-value-stocks-perfect-retirement-144500597.html?.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Allergan plc. (AGN) Ex-Dividend Date Scheduled for November 16, 2017"|"2017-11-15T14:12:22.000+00:00"|"Allergan plc AGN will begin trading ex dividend on November 16 2017 A cash dividend payment of 0 7 per share is scheduled to be paid on December 15 2017 Shareholders who purchased AGN prior to the ex dividend date are eligible for the cash dividend payment This marks the 4th"|"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YM4Kh48fKUE/allergan-plc-agn-ex-dividend-date-scheduled-for-november-16-2017-cm877628"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Pfizer Inc. :PFE-US: Earnings Analysis: Q3, 2017 By the Numbers : November 15, 2017"|"2017-11-15T13:59:58.000+00:00"|"Categories:  Yahoo FinanceGet free summary analysis Pfizer Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Pfizer Inc. – Merck & Co., Inc., Johnson & Johnson, Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis AG Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Mylan N.V., ... Read more
<b>(Read more...)</b>"|"http://finance.yahoo.com/r/5b16dfeb-6de3-3e6c-9bac-f7ccdc702f08/pfizer-inc-pfe-us-earnings-analysis-q3-2017-by-the-numbers-november-15-2017?yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
"PFE"|"PFE:US"|"BBG000BR2B91"|"Inside Novartis’s Ophthalmology Drugs Now"|"2017-11-15T12:32:32.000+00:00"|"In 3Q17, Novartis's (NVS) Lucentis generated revenues of ~$481 million, which was ~5% higher YoY (year-over-year) and 1% higher QoQ (quarter-over-quarter)."|"http://finance.yahoo.com/r/f5b3881f-cc43-3562-a692-8f1e95603a33/inside-novartiss-ophthalmology-drugs-now?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss"|4893|100|2|49|1
